AEPCX | FCADX | AEPCX / FCADX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 20 years | - |
Gain YTD | 4.355 | 3.970 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 130B | 9.61B | 1,352% |
Annual Yield % from dividends | 0.81 | 0.68 | 118% |
Returns for 1 year | 4.56 | 15.03 | 30% |
Returns for 3 years | -6.53 | 2.53 | -258% |
Returns for 5 years | 0.91 | 11.66 | 8% |
Returns for 10 years | 17.00 | 33.97 | 50% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MBCC | 35.51 | 0.37 | +1.06% |
Monarch Blue Chips Core ETF | |||
DIVS | 29.30 | N/A | -0.01% |
SmartETFs Dividend Builder ETF | |||
BIS | 17.21 | -0.04 | -0.23% |
ProShares UltraShort Nasdaq Biotech | |||
HYGH | 87.34 | -0.35 | -0.40% |
iShares Interest Rate Hdg Hi Yld Bd ETF | |||
ICF | 60.41 | -1.10 | -1.79% |
iShares Cohen & Steers REIT ETF |